BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 1983345)

  • 1. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
    Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
    Rogers MJ; Holmfield JH; Primrose JN; Johnston D
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
    Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
    Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
    Smith JT; Gavey C; Nwokolo CU; Pounder RE
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():47-63. PubMed ID: 1983346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
    Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
    Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of acid suppression during dosing with H2-receptor antagonists.
    Wilder-Smith C; Halter F; Ernst T; Gennoni M; Zeyen B; Varga L; Roehmel JJ; Merki HS
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():15-27. PubMed ID: 1983344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of 24-hour acidity by nizatidine].
    Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
    Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral famotidine on 24-hour intragastric acidity.
    Santana IA; Lanzon-Miller S; Pounder RE
    Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
    Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
    Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man.
    Nwokolo CU; Sawyerr A; Smith JT; Pounder RE
    Aliment Pharmacol Ther; 1990; 4 Suppl 1():75-83. PubMed ID: 1983349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of successive doses of nizatidine, cimetidine and ranitidine on serum gastrin level and gastric acid secretion.
    Yamaji Y; Omata T; Abe T; Yoshida A; Ueki S; Aita H; Morita H; Chaki K; Segawa Y; Kurimoto T
    Arzneimittelforschung; 1991 Sep; 41(9):954-7. PubMed ID: 1796924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
    Fullarton GM; Macdonald AM; McColl KE
    Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
    Decktor DL; Pendleton RG; Kellner AT; Davis MA
    J Pharmacol Exp Ther; 1989 Apr; 249(1):1-5. PubMed ID: 2565384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
    Lachman L; Howden CW
    Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients.
    Walt RP; Malé PJ; Hunt RH; Rawlings J; Milton-Thompson GJ; Misiewicz JJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():33-7. PubMed ID: 6119780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of histamine H(2)-receptor antagonists on human plasma levels of calcitonin gene-related peptide, substance P and vasoactive intestinal peptide.
    Itoh H; Naito T; Takeyama M
    J Pharm Pharmacol; 2002 Nov; 54(11):1559-63. PubMed ID: 12495560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 24-hour acid suppression profile of nizatidine.
    Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
    Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.